Recently, it was shown that in MDA-MB-231 BC cell line, the suppression of MED28 expression attenuates the mesenchymal morphology and downregulates the NFkB transcription factors, together with a reduction in mesenchymal biomarkers [83]. The gene discussed is MED28; the disease is breast cancer.